Funding Opportunity for Developing Outcome Measures for Autism Research

The Simons Foundation Autism Research Initiative (SFARI) requests applications for research on novel outcome measures related to autism spectrum disorder (ASD). Grants will be awarded to projects that develop and validate outcome measures suitable for clinical intervention studies on the treatment of core symptoms of ASD, such as impairment in social communication and interaction. Proposed measures should reliably assess treatment effects of behavioral or pharmacological interventions.

The grant will fund up to $300,000 per year for three years. If interested, psychological scientists should send an email notice of intent to SFARI before submitting an application.

SFARI seeks to support research that determines whether an outcome measure meets the following criteria:

  1. Reflects clinically meaningful differences in the core symptoms of ASD
  2. Has strong test-retest and interrater reliability
  3. Demonstrated sensitivity to change
  4. Presents an acceptable burden for subjects and families
  5. Is scalable for multisite trials with up to 1,000 subjects

SFARI encourages applications for outcome measures that are applicable across a wide range of ages and levels of functioning, and that capture data in naturalistic environments when possible.

Access the ASD request for applications and further information by clicking here.

Investigators who intend to submit a proposal should email a notice of intent to SFARI by February 15, 2019. The application deadline is March 1, 2019.


APS regularly opens certain online articles for discussion on our website. Effective February 2021, you must be a logged-in APS member to post comments. By posting a comment, you agree to our Community Guidelines and the display of your profile information, including your name and affiliation. Any opinions, findings, conclusions, or recommendations present in article comments are those of the writers and do not necessarily reflect the views of APS or the article’s author. For more information, please see our Community Guidelines.

Please login with your APS account to comment.